16-bromoepiandrosterone has been researched along with Tuberculosis, Pulmonary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Leon, D; Ahlem, C; Frincke, J; Hernández-Pando, R; Orozco, H; Reading, C; Rook, GA; Schramm, B; Serrano, A; Trauger, R | 1 |
1 other study(ies) available for 16-bromoepiandrosterone and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis.
Topics: Adjuvants, Immunologic; Androsterone; Animals; Chemotherapy, Adjuvant; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Th1 Cells; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2005 |